Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yunhao Chen

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Molecular Pharmaceutics|March 26, 2024
Correction to "PET Imaging of Peptide Probe Al[<sup>18</sup>F]F-NOTA-PCP1 for Monitoring the Engagement of PD-L1 Antibodies in Tumors"Yang Zhang, Yong Wang, Yunhao Chen, et al.
Molecular Therapy. Nucleic Acids|December 16, 2019
LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma CellsYunhao Chen, Hui Zhao, Haibo Li, et al.
Frontiers in Bioengineering and Biotechnology|April 8, 2024
Systematic investigation of TetR-family transcriptional regulators and their roles on lignocellulosic inhibitor acetate tolerance in <i>Zymomonas mobilis</i>Yubei Xiao, Tongjia Qin, Shuche He, et al.
Molecular Pharmaceutics|January 31, 2024
PET Imaging of Peptide Probe Al[<sup>18</sup>F]F-NOTA-PCP1 for Monitoring the Engagement of PD-L1 Antibodies in TumorsYang Zhang, Yong Wang, Yunhao Chen, et al.
Cancer Letters|September 14, 2021
VIRMA contributes to non-small cell lung cancer progression via N<sup>6</sup>-methyladenosine-dependent DAPK3 post-transcriptional modificationYongfang Xu, Yunhao Chen, Yinan Yao, et al.
Cell Death Discovery|October 28, 2021
RBM15 promotes hepatocellular carcinoma progression by regulating N6-methyladenosine modification of YES1 mRNA in an IGF2BP1-dependent mannerXianlei Cai, Yunhao Chen, Da Man, et al.
International Immunopharmacology|May 19, 2023
The current advances and future directions of PD-1/PD-L1 blockade in head and neck squamous cell carcinoma (HNSCC) in the era of immunotherapyYunhao Chen, Xingchen Ding, Xinbin Bai, et al.
JACC. Advances|June 13, 2026
Impacts of Remnant Cholesterol and Residual Inflammation on Clinical Outcomes After Ischemic StrokeYunhao Chen, Yanyu Zhu, Mingzhe Du, et al.
Science Advances|May 23, 2020
Dissolved oxygen from microalgae-gel patch promotes chronic wound healing in diabetesHuanhuan Chen, Yuhao Cheng, Jingrun Tian, et al.
Molecular Therapy. Nucleic Acids|December 26, 2022
Retraction Notice to: LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma CellsYunhao Chen, Hui Zhao, Haibo Li, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Molecular Pharmaceutics|March 26, 2024
Correction to "PET Imaging of Peptide Probe Al[<sup>18</sup>F]F-NOTA-PCP1 for Monitoring the Engagement of PD-L1 Antibodies in Tumors"Yang Zhang, Yong Wang, Yunhao Chen, et al.
Molecular Therapy. Nucleic Acids|December 16, 2019
LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma CellsYunhao Chen, Hui Zhao, Haibo Li, et al.
Frontiers in Bioengineering and Biotechnology|April 8, 2024
Systematic investigation of TetR-family transcriptional regulators and their roles on lignocellulosic inhibitor acetate tolerance in <i>Zymomonas mobilis</i>Yubei Xiao, Tongjia Qin, Shuche He, et al.
Molecular Pharmaceutics|January 31, 2024
PET Imaging of Peptide Probe Al[<sup>18</sup>F]F-NOTA-PCP1 for Monitoring the Engagement of PD-L1 Antibodies in TumorsYang Zhang, Yong Wang, Yunhao Chen, et al.
Cancer Letters|September 14, 2021
VIRMA contributes to non-small cell lung cancer progression via N<sup>6</sup>-methyladenosine-dependent DAPK3 post-transcriptional modificationYongfang Xu, Yunhao Chen, Yinan Yao, et al.
Cell Death Discovery|October 28, 2021
RBM15 promotes hepatocellular carcinoma progression by regulating N6-methyladenosine modification of YES1 mRNA in an IGF2BP1-dependent mannerXianlei Cai, Yunhao Chen, Da Man, et al.
International Immunopharmacology|May 19, 2023
The current advances and future directions of PD-1/PD-L1 blockade in head and neck squamous cell carcinoma (HNSCC) in the era of immunotherapyYunhao Chen, Xingchen Ding, Xinbin Bai, et al.
JACC. Advances|June 13, 2026
Impacts of Remnant Cholesterol and Residual Inflammation on Clinical Outcomes After Ischemic StrokeYunhao Chen, Yanyu Zhu, Mingzhe Du, et al.
Science Advances|May 23, 2020
Dissolved oxygen from microalgae-gel patch promotes chronic wound healing in diabetesHuanhuan Chen, Yuhao Cheng, Jingrun Tian, et al.
Molecular Therapy. Nucleic Acids|December 26, 2022
Retraction Notice to: LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma CellsYunhao Chen, Hui Zhao, Haibo Li, et al.
Pageof 9